Antigen-specific immune tolerance, which possesses great potential in preventing or curing
type 1 diabetes mellitus (T1DM), can be induced by oral vaccination with T1DM-related
autoantigens. However, direct administration of
autoantigens via oral route exhibits a low tolerance-inducing effect as a result of the digestion of
protein antigens in the gastrointestinal tract (GIT) and therefore, a large dosage of
autoantigens may be needed. In this study, bacterium-like particles (BLPs) made from food-grade lactic acid bacteria were used to deliver the intracellular domain of the
insulinoma-associated protein 2 (IA-2ic). For this purpose, BLPs-IA-2ic
vaccine in which IA-2ic bound to the surface of BLPs was constructed. BLPs enhanced the stability of the delivered IA-2ic based on the stability analysis in vitro.
Oral administration of BLPs-IA-2ic significantly reduced T1DM incidence in NOD mice. The mice fed BLPs-IA-2ic exhibited a significant reduction in insulitis and preserved the ability to secrete
insulin. Immunologic analysis showed that oral vaccination with BLPs-IA-2ic induced
antigen-specific T cell tolerance. The results revealed that the successful induction of immune tolerance was dependent on the immune deviation (in favor of T helper 2 responses) and CD4+CD25+FoxP3+ regulatory T cells. Hence, oral vaccination with BLPs-IA-2ic shows potential for application in preventing T1DM.